{"id":"https://openalex.org/W3081978010","doi":"https://doi.org/10.1152/ajprenal.00003.2020","title":"Praliciguat inhibits progression of diabetic nephropathy in ZSF1 rats and suppresses inflammation and apoptosis in human renal proximal tubular cells","display_name":"Praliciguat inhibits progression of diabetic nephropathy in ZSF1 rats and suppresses inflammation and apoptosis in human renal proximal tubular cells","publication_year":2020,"publication_date":"2020-08-31","ids":{"openalex":"https://openalex.org/W3081978010","doi":"https://doi.org/10.1152/ajprenal.00003.2020","mag":"3081978010","pmid":"https://pubmed.ncbi.nlm.nih.gov/32865013"},"language":"en","primary_location":{"id":"doi:10.1152/ajprenal.00003.2020","doi":"https://doi.org/10.1152/ajprenal.00003.2020","is_oa":true,"landing_page_url":"https://doi.org/10.1152/ajprenal.00003.2020","pdf_url":"https://journals.physiology.org/doi/pdf/10.1152/ajprenal.00003.2020?download=true","source":{"id":"https://openalex.org/S200780590","display_name":"American Journal of Physiology-Renal Physiology","issn_l":"1522-1466","issn":["1522-1466","1931-857X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320261","host_organization_name":"American Physical Society","host_organization_lineage":["https://openalex.org/P4310320261"],"host_organization_lineage_names":["American Physical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Physiology-Renal Physiology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://journals.physiology.org/doi/pdf/10.1152/ajprenal.00003.2020?download=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101707895","display_name":"Guang Liu","orcid":"https://orcid.org/0000-0003-4745-7641","observed_orcids":["https://orcid.org/0000-0003-4745-7641"]},"institutions":[{"id":"https://openalex.org/I4210165317","display_name":"Cyclerion (United States)","ror":"https://ror.org/05tzg1b68","country_code":"US","type":"company","lineage":["https://openalex.org/I4210165317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guang Liu","raw_affiliation_strings":["Department of Pharmacology, Cyclerion Therapeutics, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Cyclerion Therapeutics, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210165317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089975427","display_name":"Courtney M. Shea","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165317","display_name":"Cyclerion (United States)","ror":"https://ror.org/05tzg1b68","country_code":"US","type":"company","lineage":["https://openalex.org/I4210165317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Courtney M. Shea","raw_affiliation_strings":["Department of Pharmacology, Cyclerion Therapeutics, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Cyclerion Therapeutics, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210165317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103015775","display_name":"Juli E. Jones","orcid":"https://orcid.org/0000-0002-3870-1705","observed_orcids":["https://orcid.org/0000-0002-3870-1705"]},"institutions":[{"id":"https://openalex.org/I4210165317","display_name":"Cyclerion (United States)","ror":"https://ror.org/05tzg1b68","country_code":"US","type":"company","lineage":["https://openalex.org/I4210165317"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Juli E. Jones","raw_affiliation_strings":["Department of Pharmacology, Cyclerion Therapeutics, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Cyclerion Therapeutics, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210165317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025562968","display_name":"Gavrielle M. Price","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165317","display_name":"Cyclerion (United States)","ror":"https://ror.org/05tzg1b68","country_code":"US","type":"company","lineage":["https://openalex.org/I4210165317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gavrielle M. Price","raw_affiliation_strings":["Department of Medical Writing, Cyclerion Therapeutics, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Writing, Cyclerion Therapeutics, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210165317"]}]},{"author_position":"middle","author":{"id":null,"display_name":"William Warren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I169613989","display_name":"Ironwood Pharmaceuticals (United States)","ror":"https://ror.org/05v86fk30","country_code":"US","type":"company","lineage":["https://openalex.org/I169613989"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William Warren","raw_affiliation_strings":["Department of Analytical Pharmacology, Ironwood Pharmaceuticals, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Analytical Pharmacology, Ironwood Pharmaceuticals, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I169613989"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053217600","display_name":"Elisabeth Lonie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I169613989","display_name":"Ironwood Pharmaceuticals (United States)","ror":"https://ror.org/05v86fk30","country_code":"US","type":"company","lineage":["https://openalex.org/I169613989"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elisabeth Lonie","raw_affiliation_strings":["Department of Analytical Pharmacology, Ironwood Pharmaceuticals, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Analytical Pharmacology, Ironwood Pharmaceuticals, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I169613989"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101843998","display_name":"Shu Yan","orcid":"https://orcid.org/0000-0003-3655-7559","observed_orcids":["https://orcid.org/0000-0003-3655-7559"]},"institutions":[{"id":"https://openalex.org/I4210165317","display_name":"Cyclerion (United States)","ror":"https://ror.org/05tzg1b68","country_code":"US","type":"company","lineage":["https://openalex.org/I4210165317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shu Yan","raw_affiliation_strings":["Department of Discovery Informatics, Cyclerion Therapeutics, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Discovery Informatics, Cyclerion Therapeutics, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210165317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111525044","display_name":"Mark G. Currie","orcid":"https://orcid.org/0009-0007-2239-5014","observed_orcids":["https://orcid.org/0009-0007-2239-5014"]},"institutions":[{"id":"https://openalex.org/I4210165317","display_name":"Cyclerion (United States)","ror":"https://ror.org/05tzg1b68","country_code":"US","type":"company","lineage":["https://openalex.org/I4210165317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark G. Currie","raw_affiliation_strings":["Department of Research Management, Cyclerion Therapeutics, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Research Management, Cyclerion Therapeutics, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210165317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109975511","display_name":"Albert T. Profy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165317","display_name":"Cyclerion (United States)","ror":"https://ror.org/05tzg1b68","country_code":"US","type":"company","lineage":["https://openalex.org/I4210165317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Albert T. Profy","raw_affiliation_strings":["Department of Development Management, Cyclerion Therapeutics, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Development Management, Cyclerion Therapeutics, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210165317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045236281","display_name":"Jaime L. Masferrer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165317","display_name":"Cyclerion (United States)","ror":"https://ror.org/05tzg1b68","country_code":"US","type":"company","lineage":["https://openalex.org/I4210165317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jaime L. Masferrer","raw_affiliation_strings":["Department of Pharmacology, Cyclerion Therapeutics, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Cyclerion Therapeutics, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210165317"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084556157","display_name":"Daniel P. Zimmer","orcid":"https://orcid.org/0000-0002-2829-6398","observed_orcids":["https://orcid.org/0000-0002-2829-6398"]},"institutions":[{"id":"https://openalex.org/I4210165317","display_name":"Cyclerion (United States)","ror":"https://ror.org/05tzg1b68","country_code":"US","type":"company","lineage":["https://openalex.org/I4210165317"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Daniel P. Zimmer","raw_affiliation_strings":["Department of Pharmacology, Cyclerion Therapeutics, Cambridge, Massachusetts"],"raw_orcid":"https://orcid.org/0000-0002-2829-6398","affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Cyclerion Therapeutics, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210165317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5084556157","https://openalex.org/A5103015775"],"corresponding_institution_ids":["https://openalex.org/I4210165317"],"apc_list":null,"apc_paid":null,"fwci":1.5691,"has_fulltext":true,"cited_by_count":31,"citation_normalized_percentile":{"value":0.83712313,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"319","issue":"4","first_page":"F697","last_page":"F711"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10684","display_name":"Acute Kidney Injury Research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diabetic-nephropathy","display_name":"diabetic nephropathy","score":0.9440000057220459},{"id":"https://openalex.org/keywords/soluble-guanylate-cyclase-stimulator","display_name":"soluble guanylate cyclase stimulator","score":0.9449999928474426},{"id":"https://openalex.org/keywords/cgmp-signaling","display_name":"cGMP signaling","score":0.847000002861023},{"id":"https://openalex.org/keywords/nitric-oxide","display_name":"nitric oxide","score":0.7239999771118164},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.7229999899864197},{"id":"https://openalex.org/keywords/zsf1-rats","display_name":"ZSF1 rats","score":0.7329999804496765},{"id":"https://openalex.org/keywords/enalapril","display_name":"enalapril","score":0.9120000004768372},{"id":"https://openalex.org/keywords/renal-proximal-tubular-epithelial-cells","display_name":"renal proximal tubular epithelial cells","score":0.9380000233650208},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.7599999904632568},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9430000185966492},{"id":"https://openalex.org/keywords/transforming-growth-factor-beta","display_name":"TGF-beta","score":0.8299999833106995},{"id":"https://openalex.org/keywords/smad3","display_name":"Smad3","score":0.9330000281333923},{"id":"https://openalex.org/keywords/mcp-1","display_name":"MCP-1","score":0.9340000152587891},{"id":"https://openalex.org/keywords/renal-fibrosis","display_name":"renal fibrosis","score":0.6639999747276306},{"id":"https://openalex.org/keywords/renal-protection","display_name":"renal protection","score":0.7630000114440918}],"concepts":[{"id":"https://openalex.org/C2779922275","wikidata":"https://www.wikidata.org/wiki/Q1129105","display_name":"Diabetic nephropathy","level":3,"score":0.6806543469429016},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.646485447883606},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6305834054946899},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6066738963127136},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.558152973651886},{"id":"https://openalex.org/C164027704","wikidata":"https://www.wikidata.org/wiki/Q3491837","display_name":"Proinflammatory cytokine","level":3,"score":0.5445173382759094},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.5348281860351562},{"id":"https://openalex.org/C2780559512","wikidata":"https://www.wikidata.org/wiki/Q605709","display_name":"Fibrosis","level":2,"score":0.5233111381530762},{"id":"https://openalex.org/C2781184683","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Nephropathy","level":3,"score":0.47454318404197693},{"id":"https://openalex.org/C2779561371","wikidata":"https://www.wikidata.org/wiki/Q570197","display_name":"Proteinuria","level":3,"score":0.45961424708366394},{"id":"https://openalex.org/C2775940317","wikidata":"https://www.wikidata.org/wiki/Q422185","display_name":"Enalapril","level":4,"score":0.4336544871330261},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.36821532249450684},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.1982751488685608},{"id":"https://openalex.org/C27016395","wikidata":"https://www.wikidata.org/wiki/Q128861","display_name":"Angiotensin-converting enzyme","level":3,"score":0.15970736742019653}],"mesh":[{"descriptor_ui":"D000074268","descriptor_name":"Guanylyl Cyclase C Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004656","descriptor_name":"Enalapril","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007687","descriptor_name":"Kidney Tubules, Proximal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007687","descriptor_name":"Kidney Tubules, Proximal","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007687","descriptor_name":"Kidney Tubules, Proximal","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009393","descriptor_name":"Nephritis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009393","descriptor_name":"Nephritis","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009393","descriptor_name":"Nephritis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011924","descriptor_name":"Rats, Zucker","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018836","descriptor_name":"Inflammation Mediators","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051900","descriptor_name":"Smad3 Protein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1152/ajprenal.00003.2020","doi":"https://doi.org/10.1152/ajprenal.00003.2020","is_oa":true,"landing_page_url":"https://doi.org/10.1152/ajprenal.00003.2020","pdf_url":"https://journals.physiology.org/doi/pdf/10.1152/ajprenal.00003.2020?download=true","source":{"id":"https://openalex.org/S200780590","display_name":"American Journal of Physiology-Renal Physiology","issn_l":"1522-1466","issn":["1522-1466","1931-857X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320261","host_organization_name":"American Physical Society","host_organization_lineage":["https://openalex.org/P4310320261"],"host_organization_lineage_names":["American Physical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Physiology-Renal Physiology","raw_type":"journal-article"},{"id":"pmid:32865013","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32865013","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of physiology. Renal physiology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1152/ajprenal.00003.2020","doi":"https://doi.org/10.1152/ajprenal.00003.2020","is_oa":true,"landing_page_url":"https://doi.org/10.1152/ajprenal.00003.2020","pdf_url":"https://journals.physiology.org/doi/pdf/10.1152/ajprenal.00003.2020?download=true","source":{"id":"https://openalex.org/S200780590","display_name":"American Journal of Physiology-Renal Physiology","issn_l":"1522-1466","issn":["1522-1466","1931-857X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320261","host_organization_name":"American Physical Society","host_organization_lineage":["https://openalex.org/P4310320261"],"host_organization_lineage_names":["American Physical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Physiology-Renal Physiology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.800000011920929}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320312269","display_name":"Ironwood Pharmaceuticals, Incorporated","ror":"https://ror.org/05v86fk30"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3081978010.pdf","grobid_xml":"https://content.openalex.org/works/W3081978010.grobid-xml"},"referenced_works_count":58,"referenced_works":["https://openalex.org/W1501338414","https://openalex.org/W1557498395","https://openalex.org/W1769943683","https://openalex.org/W1912639232","https://openalex.org/W1964177773","https://openalex.org/W1970659243","https://openalex.org/W1974150901","https://openalex.org/W1978183768","https://openalex.org/W1997042641","https://openalex.org/W1997314757","https://openalex.org/W1999575142","https://openalex.org/W2032339573","https://openalex.org/W2034578084","https://openalex.org/W2044747742","https://openalex.org/W2055237834","https://openalex.org/W2063446728","https://openalex.org/W2078408369","https://openalex.org/W2080969909","https://openalex.org/W2085054033","https://openalex.org/W2085510141","https://openalex.org/W2100609281","https://openalex.org/W2101457616","https://openalex.org/W2104274897","https://openalex.org/W2114598208","https://openalex.org/W2120753380","https://openalex.org/W2121633948","https://openalex.org/W2129347273","https://openalex.org/W2131711634","https://openalex.org/W2134268527","https://openalex.org/W2134644953","https://openalex.org/W2139415978","https://openalex.org/W2147372811","https://openalex.org/W2160364889","https://openalex.org/W2161975000","https://openalex.org/W2172207849","https://openalex.org/W2225473766","https://openalex.org/W2260347811","https://openalex.org/W2281691222","https://openalex.org/W2326963272","https://openalex.org/W2342324400","https://openalex.org/W2344962666","https://openalex.org/W2412375591","https://openalex.org/W2414232855","https://openalex.org/W2512638651","https://openalex.org/W2739025552","https://openalex.org/W2777236800","https://openalex.org/W2782630985","https://openalex.org/W2792698977","https://openalex.org/W2795751760","https://openalex.org/W2797298193","https://openalex.org/W2805363220","https://openalex.org/W2807216398","https://openalex.org/W2945377690","https://openalex.org/W2954444916","https://openalex.org/W2980858331","https://openalex.org/W2995764953","https://openalex.org/W3016029207","https://openalex.org/W3035243246"],"related_works":["https://openalex.org/W6901845443","https://openalex.org/W3112831521","https://openalex.org/W2980858331","https://openalex.org/W4210538298","https://openalex.org/W4396996981","https://openalex.org/W3035243246","https://openalex.org/W2113698834","https://openalex.org/W2225473766","https://openalex.org/W2035691671","https://openalex.org/W2112537147"],"abstract_inverted_index":{"Praliciguat,":[0],"a":[1,174],"clinical-stage":[2],"soluble":[3],"guanylate":[4],"cyclase":[5],"(sGC)":[6],"stimulator,":[7],"increases":[8],"cGMP":[9,221],"via":[10],"the":[11,32,45,122,126,148,190,218],"nitric":[12],"oxide-sGC":[13],"pathway.":[14],"Praliciguat":[15,53,146,164],"has":[16],"been":[17],"shown":[18],"to":[19,117,173,209],"be":[20],"renoprotective":[21],"in":[22,38,44,75,78,88,94,136,159,182,189,200,223],"rodent":[23],"models":[24],"of":[25,50,73,128,150,155,180,194,220],"hypertensive":[26],"nephropathy":[27],"and":[28,37,83,100,133,153,178,197],"renal":[29,140,211,224],"fibrosis.":[30],"In":[31,59,184],"present":[33],"study,":[34],"praliciguat":[35,106,129,186],"alone":[36],"combination":[39],"with":[40,105],"enalapril":[41,61],"attenuated":[42,167],"proteinuria":[43,188],"obese":[46,90,95],"ZSF1":[47,91,191],"rat":[48,192],"model":[49,193],"diabetic":[51,195],"nephropathy.":[52],"monotherapy":[54,62],"did":[55,67],"not":[56,68],"affect":[57],"hemodynamics.":[58],"contrast,":[60],"lowered":[63],"blood":[64],"pressure":[65],"but":[66],"attenuate":[69],"proteinuria.":[70],"Renal":[71],"expression":[72,149],"genes":[74],"pathways":[76,135],"involved":[77],"inflammation,":[79],"fibrosis,":[80],"oxidative":[81],"stress,":[82],"kidney":[84],"injury":[85],"was":[86],"lower":[87,104],"praliciguat-treated":[89],"rats":[92],"than":[93],"control":[96],"rats;":[97],"fasting":[98],"glucose":[99],"cholesterol":[101],"were":[102],"also":[103,166],"treatment.":[107],"To":[108],"gain":[109],"insight":[110],"into":[111],"how":[112],"tubular":[113,142,205],"mechanisms":[114],"might":[115],"contribute":[116,208],"its":[118,198,210],"pharmacological":[119],"effects":[120,127,206],"on":[121,130],"kidneys,":[123],"we":[124],"studied":[125],"pathological":[131],"processes":[132],"signaling":[134,222],"cultured":[137],"human":[138,201],"primary":[139],"proximal":[141],"epithelial":[143],"cells":[144],"(RPTCs).":[145],"inhibited":[147],"proinflammatory":[151],"cytokines":[152],"secretion":[154],"monocyte":[156],"chemoattractant":[157],"protein-1":[158],"tumor":[160],"necrosis":[161],"factor-\u03b1-challenged":[162],"RPTCs.":[163,183],"treatment":[165],"transforming":[168],"growth":[169],"factor-\u03b2-mediated":[170],"apoptosis,":[171],"changes":[172],"mesenchyme-like":[175],"cellular":[176],"phenotype,":[177],"phosphorylation":[179],"SMAD3":[181],"conclusion,":[185],"improved":[187],"nephropathy,":[196],"actions":[199],"RPTCs":[202],"suggest":[203],"that":[204],"may":[207],"benefits,":[212],"building":[213],"upon":[214],"strong":[215],"evidence":[216],"for":[217],"role":[219],"health.":[225]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2020-09-08T00:00:00"}